Susan Moran
CIK 1835225 · CHIEF MEDICAL OFFICER · last filed 2026-06-03
Susan Moran is a CHIEF MEDICAL OFFICER who has filed 13 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for GLYC, was dated Jun 3, 2026. Current disclosed insider exposure totals $201.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$201.9K
4
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | — | $15.70 | — | $0 | 2 | 2026-06-03 |
| TYRA | Director | — | $26.99 | — | $0 | 3 | 2026-06-01 |
| BCAB | Director | 52,307 | $3.86 | $201.9K | $0 | 5 | 2025-06-18 |
| RayzeBio, Inc. (RYZB) Delisted | CHIEF MEDICAL OFFICER | 0 | $62.49 | $0 | $0 | 3 | 2024-02-27 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-06-01 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2025-06-23 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | BCAB | Grant (A) | +23,500 | $0 | EDGAR |
| 2025-06-02 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | BCAB | Grant (A) | +16,500 | $0 | EDGAR |
| 2024-05-09 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2024-02-27 | RayzeBio, Inc. (RYZB) Delisted | Disp (D) | −323,455 | -$20.22M | EDGAR |
| 2024-02-06 | RayzeBio, Inc. (RYZB) Delisted | Exer (M) | +30,875 | $100.0K | EDGAR |
| 2023-11-17 | RayzeBio, Inc. (RYZB) Delisted | Grant (A) | — | $0 | EDGAR |